title: Hematopoietic stem and progenitor cell mobilization in mice.
abstract: Hematopoietic stem cell transplantation (HSCT) can be performed with hematopoietic stem and progenitor cells (HSPC) acquired directly from bone marrow, from umbilical cord blood or placental tissue, or from the peripheral blood after treatment of the donor with agents that enhance egress of HSPC into the circulation, a process known as "mobilization." Mobilized peripheral blood stem cells (PBSC) have become the predominate hematopoietic graft for HSCT, particularly for autologous transplants. Despite the success of PBSC transplant, many patients and donors do not achieve optimal levels of mobilization. Thus, accurate animal models and basic laboratory investigations are needed to further investigate the mechanisms that lead to PBSC mobilization and define improved or new mobilizing agents and/or strategies to enhance PBSC mobilization and transplant. This chapter outlines assays and techniques for exploration of hematopoietic mobilization using mice as a model organism.
authors: Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Sherman Fairchild Room 201, Cambridge, MA, 02138, USA, Hoggatt.Jonathan@mgh.harvard.edu.
authors: Jonathan
authors: J
authors: Hoggatt
authors: Tiffany A
authors: TA
authors: Tate
authors: Louis M
authors: LM
authors: Pelus
mesh_terms: D000818:Animals; D001772:Blood Cell Count; D004333:Drug Administration Routes; D004912:Erythrocytes / Q000166:cytology; D005260:Female; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D007700:Kinetics; D007963:Leukocytes, Mononuclear / Q000166:cytology; D008297:Male; D051379:Mice
chemical_list: D016179:Granulocyte Colony-Stimulating Factor